The DOI matches its Crossref record; 621 of the 626 references it cites were found in a registry or an index.
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Open accessAbstract
SUMMARY: Streptococcus pyogenes , also known as group A Streptococcus (GAS), causes mild human infections such as pharyngitis and impetigo and serious infections such as necrotizing fasciitis and streptococcal toxic shock syndrome. Furthermore, repeated GAS infections may trigger autoimmune diseases, including acute poststreptococcal glomerulonephritis, acute rheumatic fever, and rheumatic heart disease. Combined, these diseases account for over half a million deaths per year globally. Genomic and molecular analyses have now characterized a large number of GAS virulence determinants, many of which exhibit overlap and redundancy in the processes of adhesion and colonization, innate immune resistance, and the capacity to facilitate tissue barrier degradation and spread within the human host. This improved understanding of the contribution of individual virulence determinants to the disease process has led to the formulation of models of GAS disease progression, which may lead to better treatment and intervention strategies. While GAS remains sensitive to all penicillins and cephalosporins, rising resistance to other antibiotics used in disease treatment is an increasing worldwide concern. Several GAS vaccine formulations that elicit protective immunity in animal models have shown promise in nonhuman primate and early-stage human trials. The development of a safe and efficacious commercial human vaccine for the prophylaxis of GAS disease remains a high priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upon detection of these Gram-positive pyogenic bacteria, neutrophil recruitment is critical to the resolution of infection (2).”
From Epidermal hepcidin is required for neutrophil response to bacterial infection (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268 · cited 1×
“trophils at the site of infection to ensnare and kill bacteria (275).”
BackgroundPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 1×
“In GAS, tetracycline resistance is conferred by ribosome protection genes such as tet(M) or tet(O) (509).”
BackgroundInfectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
The global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998 · cited 8×
“A 2005 WHO study estimated that at least 663,000 cases of invasive GAS disease occur each year, resulting in 163,000 deaths (5).”
BackgroundInfluentialPlasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535 · cited 1×
“Plasmin degradation of fibrinogen can also initiate the release of products that enhance blood vessel permeability and the accumulation of inflammatory cells (330, 331).”
BackgroundPathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261 · cited 20×
“This disease burden includes over 2.4 million cases in patients aged 5 to 14 years, making RHD the most common cause of pediatric heart disease worldwide (73).”
BackgroundInfluentialPractice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, E. L., Montoya, J. G., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/497143 · Cited by 1,602
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358 · cited 1×
“SpeB cleaves and inactivates human cathelicidin LL-37 (256), a small cationic antimicrobial peptide of the innate immune system produced by skin keratinocytes, mucosal epithelial cells, and neutrophils with bactericidal activity and electrostatic affinity for negatively charged bacterial surfaces (257).”
BackgroundStevens, D. L., Tanner, M. H., Winship, J., Swarts, R., Ries, K. M., Schlievert, P. M., & Kaplan, E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210101 · Cited by 1,216
Research works printed but not linked: 8
- 10.1128/CMR.13.3.470-511.2000 · doi:10.1128/cmr.13.3.470-511.2000 · Paper page
- WHO. 2005. The current evidence for the burden of group A streptococcal diseases. WHO report. WHO, Geneva, Switzerland.
- 10.1001/jama.1983.03330310025020 · doi:10.1001/jama.1983.03330310025020
- 10.3201/eid15/2.080558 · doi:10.3201/eid15/2.080558
- 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D · doi:10.1002/1521-4141(200011)30:11<3247::aid-immu3247>3.0.co;2-d
- 10.1016/B978-0-12-385855-9.00002-3 · doi:10.1016/b978-0-12-385855-9.00002-3
- 10.1097/00019052-200306000-00017 · doi:10.1097/00019052-200306000-00017
- American Academy of Pediatrics. 2012. Group A streptococcal infections, p 668–680. In Pickering LK Baker CJ Kimberlin DW Long SS (ed), Red book: 2012 report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL.
Cited by
The wound microbiota: microbial mechanisms of impaired wound healing and infection
Uberoi, A., McCready-Vangi, A., & Grice, E. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01035-z · Cited by 864
“Interestingly, most adhesin proteins are not present universally across all GAS strains and it is thought that expression and/or regulation of adhesins plays a role in determining tissue tropism of GAS bacteria 79 .”
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Karki, R., & Kanneganti, T.-D. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.06.001 · Cited by 438
Pathogenesis, epidemiology and control of Group A Streptococcus infection
Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00865-7 · Cited by 374
Self-citationEmerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
“By understanding the dynamics of disease and the means of contracting it, methods of fighting, preventing, and controlling are developed [2, 5, 6].”
Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K., & Condon, J. R. (2013) · Circulation · doi:10.1161/circulationaha.113.001477 · Cited by 282
Metadata
- Authors
- Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V.
- Affiliations
- The University of Queensland (AU)
- University of Wollongong (AU)
- QIMR Berghofer Medical Research Institute (AU)
- School of Biological Sciences and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia
- University of California San Diego (US)
- Corresponding author
- Walker, Mark J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2014-04
- Volume
- 27
- Issue
- 2
- Pages
- 264-301
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC3993104
- OpenAlex
- W2145736155
- Cited by
- 908
- References
- 626
- Citations by year
- 2026: 74 · 2025: 85 · 2024: 96 · 2023: 81 · 2022: 82 · 2021: 87 · 2020: 91 · 2019: 76 · 2018: 57 · 2017: 59 · 2016: 55 · 2015: 50 · 2014: 12
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Online (University of Wollongong) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI077780)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052728)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- Streptococcus pyogenes, virulence factors, pathogenesis, pharyngitis, impetigo, necrotizing fasciitis, toxic shock syndrome, post-streptococcal glomerulonephritis, rheumatic fever, rheumatic heart disease, innate immune evasion, tissue degradation, antibiotic resistance, streptococcal vaccine, disease progression model
- MeSH terms
- Animals, Anti-Bacterial Agents, Disease Models, Animal, Humans, Streptococcal Infections, Streptococcus pyogenes, Virulence, Streptococcal Vaccines, Drug Resistance, Bacterial, Virulence Factors, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus. https://app.cochat.ai/papers/10.1128/cmr.00101-13
- The paper
- Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014). Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00101-13
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.